{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:19:54Z","timestamp":1772889594734,"version":"3.50.1"},"reference-count":90,"publisher":"Informa UK Limited","issue":"15","funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","award":["SFRH\/BD\/64441\/2009"],"award-info":[{"award-number":["SFRH\/BD\/64441\/2009"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.2217\/pgs-2016-0067","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T12:00:17Z","timestamp":1474977617000},"page":"1649-1674","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":34,"title":["Moving Toward Personalized Medicine in Rheumatoid Arthritis: Snps in Methotrexate Intracellular Pathways are Associated with Methotrexate Therapeutic Outcome"],"prefix":"10.1080","volume":"17","author":[{"given":"Aurea","family":"Lima","sequence":"first","affiliation":[{"name":"CESPU, Institute of Research & Advanced Training in Health Sciences & Technologies, Department of Pharmaceutical Sciences","place":["Gandra, Portugal"]},{"name":"Molecular Oncology & Viral Pathology Group \u2013 Research Center, Portuguese Institute of Oncology of Porto (IPO-Porto), Rua Dr. Ant\u00f3nio Bernardino de Almeida","place":["Porto, Portugal"]},{"name":"Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]}]},{"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[{"name":"Faculty of Medicine of University of Porto (FMUP), Al. Prof. Hern\u00e2ni Monteiro","place":["Porto, Portugal"]},{"name":"Rheumatology Department of S\u00e3o Jo\u00e3o Hospital Center, Al. Prof. Hern\u00e2ni Monteiro","place":["Portugal"]}]},{"given":"Rita","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"Experimental Pathology & Therapeutics Group \u2013 Research Center, Portuguese Institute of Oncology of Porto (IPO-Porto), Rua Dr. Ant\u00f3nio Bernardino de Almeida","place":["Porto, Portugal"]}]},{"given":"Vitor","family":"Seabra","sequence":"additional","affiliation":[{"name":"CESPU, Institute of Research & Advanced Training in Health Sciences & Technologies, Department of Pharmaceutical Sciences","place":["Gandra, Portugal"]}]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Molecular Oncology & Viral Pathology Group \u2013 Research Center, Portuguese Institute of Oncology of Porto (IPO-Porto), Rua Dr. Ant\u00f3nio Bernardino de Almeida","place":["Porto, Portugal"]},{"name":"Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"Research Department-Portuguese League Against Cancer (LPCC-NRNorte)","place":["Porto, Portugal"]}]}],"member":"301","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0857-7"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.23.2869"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15640-7"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/368681"},{"issue":"5","key":"e_1_3_5_7_1","first-page":"E427","article-title":"Painful rheumatoid arthritis","volume":"14","author":"Smith HS","year":"2011","unstructured":"Smith HS , SmithAR , SeidnerP . Painful rheumatoid arthritis . Pain Physician14 ( 5 ), E427 \u2013 E458 ( 2011 ).","journal-title":"Pain Physician"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/845496"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780371013"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20278"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8564-6"},{"issue":"17","key":"e_1_3_5_12_1","first-page":"1","article-title":"Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?","volume":"11","author":"Romao VC","year":"2013","unstructured":"Romao VC , CanhaoH , FonsecaJE . Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?BMC Med.11 ( 17 ), 1 \u2013 24 ( 2013 ).","journal-title":"BMC Med."},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.116"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.25"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.244"},{"issue":"3","key":"e_1_3_5_16_1","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian H","year":"2007","unstructured":"Tian H , CronsteinBN . Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis . Bull. NYU Hosp. Jt. Dis.65 ( 3 ), 168 \u2013 173 ( 2007 ).","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"issue":"4","key":"e_1_3_5_17_1","first-page":"473","article-title":"Methotrexate in rheumatoid arthritis","volume":"58","author":"Swierkot J","year":"2006","unstructured":"Swierkot J , SzechinskiJ . Methotrexate in rheumatoid arthritis . Pharmacol. Rep.58 ( 4 ), 473 \u2013 492 ( 2006 ).","journal-title":"Pharmacol. Rep."},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar419"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.118"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-13-RV-119"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22129"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24034"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2520489"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)34190-X"},{"issue":"34","key":"e_1_3_5_25_1","first-page":"177","article-title":"Purine de novo synthesis-mechanisms and clinical implications","volume":"13","author":"Adam T","year":"2005","unstructured":"Adam T . Purine de novo synthesis-mechanisms and clinical implications . Klin. Biochem. Metab.13 ( 34 ), 177 \u2013 181 ( 2005 ).","journal-title":"Klin. Biochem. Metab."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.281.4.F597"},{"key":"e_1_3_5_27_1","first-page":"27","article-title":"Adenosine metabolism in the guinea pig heart: the role of cytosolic S-adenosyl-L-homocysteine hydrolase, 5\u2032-nucleotidase and adenosine kinase","volume":"14","author":"Lloyd HG","year":"1993","unstructured":"Lloyd HG , SchraderJ . Adenosine metabolism in the guinea pig heart: the role of cytosolic S-adenosyl-L-homocysteine hydrolase, 5\u2032-nucleotidase and adenosine kinase . Eur. Heart. J.14 ( Suppl. I ), 27 \u2013 33 ( 1993 ).","journal-title":"Eur. Heart. J."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00580802"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.280.6.F945"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.8.729"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.048637"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10712"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.2.3"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfu162"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108165"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160613760"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138461"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"e_1_3_5_39_1","unstructured":"U.S. Department of Health and Human Services . Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03 ( 2010 ). http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf ."},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20460"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22032"},{"issue":"4","key":"e_1_3_5_42_1","first-page":"562","article-title":"Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis","volume":"35","author":"James HM","year":"2008","unstructured":"James HM , GillisD , HissariaPet al. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis . J. Rheumatol.35 ( 4 ), 562 \u2013 571 ( 2008 ).","journal-title":"J. Rheumatol."},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328331b53e"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283398a71"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.111567"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.83"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-11-RG-066"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2012.7"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken513"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.2.275"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-228-1_11"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btl268"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/978396"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.033571"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.08.008"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-2607(95)01703-8"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.114.164814"},{"issue":"3","key":"e_1_3_5_59_1","first-page":"324","article-title":"Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis","volume":"32","author":"Davis LA","year":"2014","unstructured":"Davis LA , PolkB , MannAet al. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis . Clin. Exp. Rheumatol.32 ( 3 ), 324 \u2013 332 ( 2014 ).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01046.x"},{"issue":"3","key":"e_1_3_5_61_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.20452\/pamw.2707","article-title":"Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR, TYMS and TCII and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis","volume":"125","author":"Swierkot J","year":"2015","unstructured":"Swierkot J , SlezakR , KarpinskiPet al. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR, TYMS and TCII and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis . Pol. Arch. Med. Wewn.125 ( 3 ), 152 \u2013 61 ( 2015 ).","journal-title":"Pol. Arch. Med. Wewn."},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(98)80049-8"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.86"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1086\/301825"},{"issue":"5","key":"e_1_3_5_65_1","first-page":"728","article-title":"Associations between the genetic polymorphisms of MTHFR and outcomes of methotrexate treatment in rheumatoid arthritis","volume":"28","author":"Xiao H","year":"2010","unstructured":"Xiao H , XuJ , ZhouXet al. Associations between the genetic polymorphisms of MTHFR and outcomes of methotrexate treatment in rheumatoid arthritis . Clin. Exp. Rheumatol.28 ( 5 ), 728 \u2013 733 ( 2010 ).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21726"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3219-z"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP202242"},{"issue":"3","key":"e_1_3_5_69_1","first-page":"499","article-title":"Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients","volume":"27","author":"Taraborelli M","year":"2009","unstructured":"Taraborelli M , AndreoliL , ArchettiSet al. Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients . Clin. Exp. Rheumatol.27 ( 3 ), 499 \u2013 502 ( 2009 ).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.617312"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0142"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2011.42"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1989-5"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2010.32"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0521-7"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00079-3"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2009.00156"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3205"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi020536s"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.67"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21573"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken182"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.14.6457"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22640"},{"issue":"3","key":"e_1_3_5_86_1","first-page":"268","article-title":"Glutathione S-transferase gene polymorphisms in Japanese patients with rheumatoid arthritis","volume":"24","author":"Morinobu S","year":"2006","unstructured":"Morinobu S , MorinobuA , KanagawaSet al. Glutathione S-transferase gene polymorphisms in Japanese patients with rheumatoid arthritis . Clin. Exp. Rheumatol.24 ( 3 ), 268 \u2013 273 ( 2006 ).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.3.164"},{"issue":"6","key":"e_1_3_5_88_1","first-page":"1037","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"72","author":"Rindfleisch JA","year":"2005","unstructured":"Rindfleisch JA , MullerD . Diagnosis and management of rheumatoid arthritis . Am. Fam. Physician72 ( 6 ), 1037 \u2013 1047 ( 2005 ).","journal-title":"Am. Fam. Physician"},{"issue":"13","key":"e_1_3_5_89_1","first-page":"S295","article-title":"Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis","volume":"18","author":"Gibofsky A","year":"2012","unstructured":"Gibofsky A . Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis . Am. J. Manag. Care18 ( Suppl. 13 ), S295 \u2013 S302 ( 2012 ).","journal-title":"Am. J. Manag. Care"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32833f2cd0"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111593"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.150"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2016-0067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:01:29Z","timestamp":1762171289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2016-0067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":90,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.2217\/pgs-2016-0067"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2016-0067","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-04-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}